Actively Recruiting

FEMALE
NCT06129968

Transforming Ovarian Cancer Diagnostic Pathways

Led by Professor Sudha Sundar · Updated on 2025-05-16

34000

Participants Needed

3

Research Sites

79 weeks

Total Duration

On this page

Sponsors

P

Professor Sudha Sundar

Lead Sponsor

U

University of Birmingham

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this observational cohort study is to compare the diagnostic accuracy and cost effectiveness of Risk of Malignancy Algorithm (ROMA) compared with CA125 in the diagnosis of ovarian cancer in patients attending their general practitioner (GP) with symptoms that sometimes might indicate ovarian cancer. The main questions it aims to answer are: • what is the accuracy of the ROMA algorithm which uses the blood tests CA125 and Human epididymis protein 4 (HE4) compared to CA125 in diagnosing ovarian cancer, particularly early-stage ovarian cancer, in women tested for suspected ovarian cancer from primary care? • What is the cost-effectiveness of ROMA versus CA125 testing in primary care to diagnose ovarian cancer? When a participant's GP orders a CA125 blood test, the blood will also be tested for HE4 and the ROMA algorithm calculated. The diagnostic accuracy of ROMA and CA125 will be compared to see if ROMA would be a better diagnostic test for ovarian cancer when used in the primary care setting.

CONDITIONS

Official Title

Transforming Ovarian Cancer Diagnostic Pathways

Who Can Participate

FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women presenting to primary care with suspected ovarian cancer who are tested for the biomarker CA125 according to current standards of care for investigation of CA125 in the primary care setting.
Not Eligible

You will not qualify if you...

  • Patients presenting to primary care who do not have potential symptoms of ovarian cancer.
  • Women with symptoms sometimes associated with ovarian cancer not tested for ovarian cancer.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Sandwell and West Birmingham NHS TRUST

Birmingham, United Kingdom

Not Yet Recruiting

2

Gateshead Health NHS Foundation Trust

Gateshead, United Kingdom

Actively Recruiting

3

The Royal Wolverhampton NHS Trust

Wolverhampton, United Kingdom

Actively Recruiting

Loading map...

Research Team

S

Sudha Sundar

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here